Broadfin Capital’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-505,900
Closed -$2.25M 42
2019
Q3
$2.25M Sell
505,900
-241,600
-32% -$1.01M 0.71% 38
2019
Q2
$2.89M Sell
747,500
-731,743
-49% -$3.23M 0.71% 35
2019
Q1
$5.61M Sell
1,479,243
-2,746,834
-65% -$9.71M 1.22% 31
2018
Q4
$10.1M Sell
4,226,077
-237,752
-5% -$1.18M 2.08% 23
2018
Q3
$27.7M Buy
4,463,829
+1,214,000
+37% +$6.99M 4.97% 5
2018
Q2
$14.7M Buy
3,249,829
+2,529,300
+351% +$12.6M 2.46% 16
2018
Q1
$3.31M Sell
720,529
-381,671
-35% -$1.52M 0.52% 43
2017
Q4
$3.54M Buy
+1,102,200
New +$3.08M 0.58% 35
2017
Q3
Sell
-681,346
Closed -$2.52M 46
2017
Q2
$2.52M Sell
681,346
-347,326
-34% -$1.39M 0.37% 44
2017
Q1
$5.02M Sell
1,028,672
-84,621
-8% -$417K 0.7% 35
2016
Q4
$5.7M Hold
1,113,293
0.65% 40
2016
Q3
$8.06M Hold
1,113,293
0.77% 44
2016
Q2
$6.62M Buy
1,113,293
+149,100
+15% +$1.04M 0.73% 40
2016
Q1
$7.8M Hold
964,193
0.91% 36
2015
Q4
$7.78M Hold
964,193
0.56% 55
2015
Q3
$8.06M Hold
964,193
0.64% 55
2015
Q2
$8.93M Hold
964,193
0.59% 46
2015
Q1
$9.45M Buy
964,193
+575,000
+148% +$5.79M 0.75% 38
2014
Q4
$4.35M Buy
+389,193
New +$4.45M 0.38% 55

Other funds holding ADMA